Sample | Title | Value | Rank |
GSM780707 | Untreated after 4 days (C1_1) | 233.715 | 85 |
GSM780708 | Untreated after 4 days (C2_1) | 180.144 | 82 |
GSM780709 | Untreated after 4 days (C3_1) | 168.765 | 82 |
GSM780719 | Untreated after 4 days (C1_2) | 231.729 | 85 |
GSM780720 | Untreated after 4 days (C2_2) | 194.707 | 83 |
GSM780721 | Untreated after 4 days (C3_2) | 177.709 | 82 |
GSM780710 | Trastuzumab treated after 4 days (T1_1) | 169.473 | 82 |
GSM780711 | Trastuzumab treated after 4 days (T2_1) | 234.789 | 85 |
GSM780712 | Trastuzumab treated after 4 days (T3_1) | 204.023 | 84 |
GSM780722 | Trastuzumab treated after 4 days (T1_2) | 175.647 | 82 |
GSM780723 | Trastuzumab treated after 4 days (T2_2) | 231.424 | 85 |
GSM780724 | Trastuzumab treated after 4 days (T3_2) | 214.929 | 84 |
GSM780713 | Pertuzumab treated after 4 days (P1_1) | 226.51 | 85 |
GSM780714 | Pertuzumab treated after 4 days (P2_1) | 175.647 | 82 |
GSM780715 | Pertuzumab treated after 4 days (P3_1) | 227.725 | 85 |
GSM780725 | Pertuzumab treated after 4 days (P1_2) | 240.745 | 85 |
GSM780726 | Pertuzumab treated after 4 days (P2_2) | 194.015 | 83 |
GSM780727 | Pertuzumab treated after 4 days (P3_2) | 211.15 | 84 |
GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 205.038 | 84 |
GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 223.434 | 85 |
GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 220.043 | 85 |
GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 227.725 | 85 |
GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 220.79 | 85 |